Lorazepam Tablet
Product Images NDC 13107-084

4 FDA label images from Aurolife Pharma Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 13107-084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurolife Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Lorazepam Str)

Chemical-structure (Lorazepam Str)
Chemical structure of lorazepam, showing the molecular formula C15H10Cl2N2O2 and a molecular weight of 321.16.*
FDA Label Image

Lorazepam0.5mg100ct.jpg (Lorazepam0.5mg100ct)

Lorazepam0.5mg100ct.jpg (Lorazepam0.5mg100ct)
Label for Lorazepam Tablets, USP 0.5 mg in tablet form, produced by Aurobindo Pharma USA, Inc. The label denotes this as prescription medication, packaged with 100 tablets per container, and includes storage instructions and a note to see the package insert for dosage. The label highlights the strength of 0.5 mg and mentions controlled room temperature storage guidelines.*
FDA Label Image

Lorazepam1mg100ct.jpg (Lorazepam1mg100ct)

Lorazepam1mg100ct.jpg (Lorazepam1mg100ct)
Lorazepam Tablets USP 1 mg oral tablets label displaying the product name, strength, and dosage form. The label indicates prescription status (Rx only), contains 100 tablets, and provides storage, dispensing, and dosage information. The labeler is Aurolife Pharma LLC, with distribution by Aurobindo Pharma USA, Inc.*
FDA Label Image

Lorazepam2mg100ct.jpg (Lorazepam2mg100ct)

Lorazepam2mg100ct.jpg (Lorazepam2mg100ct)
Label for Lorazepam Tablets USP 2 mg, oral tablets, in a package containing 100 tablets. The label includes storage instructions at 20° to 25°C, dispensing guidance, and distribution information for Aurobindo Pharma USA, Inc. The product is prescription-only and the label revision date is January 2018.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.